Research Article

Is the neutrophil/lymphocyte rate as effective as CURB-65 in the patient management of the community-acquired pneumonia patients admitted to the Emergency Medicine?

Volume: 7 Number: 2 March 4, 2021
EN

Is the neutrophil/lymphocyte rate as effective as CURB-65 in the patient management of the community-acquired pneumonia patients admitted to the Emergency Medicine?

Abstract

Objectives: The aim of this study was to identify the patients with community-acquired pneumonia (CAP) in emergency departments, and to compare CURB-65 scoring system and Neutrophil/Lymphocyte Ratio (NLO) which are some of the commonly used blood parameters to make an inpatient or outpatient decision quickly and effectively.

Methods: This study was performed retrospectively by examining the files of 442 patients who were admitted to the adult emergency department of Bursa Yüksek İhtisas Training and Research Hospital between September 1, 2017 and October 31, 2018. The demographic characteristics, physical examination findings, laboratory results, hospitalizations, and CURB-65 scores of the patients included in the study were recorded on a pre-prepared paper and electronic form and statistical analyzes of these data were conducted.

Results: Two hundred and fifty-five (57.69%) patients were male and the mean age was 70.93 years. The mean NLO value was 9.85, the mean MPV value was 8.62, the mean eosinophil value was 0.15 and the mean CURB-65 score was 1.85. When the post hoc paired group comparison was conducted for the mean NLR, it was found that the other groups differed from each other except the groups admitted to the intensive care unit and the service. Glasgow Coma Scale score and CURB-65 score were found to be significant predictors for hospitalization to service and intensive care unit (p < 0.05).

Conclusions: We think that NLR may be useful in decision-making process, especially in prospective studies, although the use of NLR in patients with CAP is not statistically significant. In this study, we also examined that CURB-65 is an effective scoring system in the management of this patient group. 

Keywords

References

  1. 1. Lanks CW, Musani AI, Hsia DW. Community-acquired pneumonia and hospital-acquired pneumonia. Med Clin North Am 2019;103:487-501.
  2. 2. The 10 leading causes of death in the world: World Health Organization 2018. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
  3. 3. Rider AC, Frazee BW. Community-acquired pneumonia. Emerg Med Clin North Am 2018;36:665-83.
  4. 4. Musher DM, Thorner AR. Community-acquired pneumonia. N Eng J Med 2014;371:1619-28.
  5. 5. Janssens JP, Krause KH. Pneumonia in the very old. Lancet Infect Dis 2004;4:112-24.
  6. 6. Bellelli G, Guerini F, Cerri AP, Trabucchi M. A sudden decline in mobility status as an early sign of acute infection in elderly patients: evidence from three case reports. Aging Clin Exp Res 2012;24:281-4.
  7. 7. Khokhar SR, Stern Y, Bell K, Anderson K, Noe E, Mayeux R, et al. Persistent mobility deficit in the absence of deficits in activities of daily living: a risk factor for mortality. J Am Geriatr Soc 2001;49:1539-43.
  8. 8. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-82.

Details

Primary Language

English

Subjects

Emergency Medicine

Journal Section

Research Article

Publication Date

March 4, 2021

Submission Date

January 21, 2020

Acceptance Date

April 23, 2020

Published in Issue

Year 2021 Volume: 7 Number: 2

APA
Barut, İ., Yüksel, M., Kaya, H., & Engindeniz, Z. (2021). Is the neutrophil/lymphocyte rate as effective as CURB-65 in the patient management of the community-acquired pneumonia patients admitted to the Emergency Medicine? The European Research Journal, 7(2), 184-191. https://doi.org/10.18621/eurj.678454
AMA
1.Barut İ, Yüksel M, Kaya H, Engindeniz Z. Is the neutrophil/lymphocyte rate as effective as CURB-65 in the patient management of the community-acquired pneumonia patients admitted to the Emergency Medicine? Eur Res J. 2021;7(2):184-191. doi:10.18621/eurj.678454
Chicago
Barut, İlker, Melih Yüksel, Halil Kaya, and Zülfi Engindeniz. 2021. “Is the Neutrophil Lymphocyte Rate As Effective As CURB-65 in the Patient Management of the Community-Acquired Pneumonia Patients Admitted to the Emergency Medicine?”. The European Research Journal 7 (2): 184-91. https://doi.org/10.18621/eurj.678454.
EndNote
Barut İ, Yüksel M, Kaya H, Engindeniz Z (March 1, 2021) Is the neutrophil/lymphocyte rate as effective as CURB-65 in the patient management of the community-acquired pneumonia patients admitted to the Emergency Medicine? The European Research Journal 7 2 184–191.
IEEE
[1]İ. Barut, M. Yüksel, H. Kaya, and Z. Engindeniz, “Is the neutrophil/lymphocyte rate as effective as CURB-65 in the patient management of the community-acquired pneumonia patients admitted to the Emergency Medicine?”, Eur Res J, vol. 7, no. 2, pp. 184–191, Mar. 2021, doi: 10.18621/eurj.678454.
ISNAD
Barut, İlker - Yüksel, Melih - Kaya, Halil - Engindeniz, Zülfi. “Is the Neutrophil Lymphocyte Rate As Effective As CURB-65 in the Patient Management of the Community-Acquired Pneumonia Patients Admitted to the Emergency Medicine?”. The European Research Journal 7/2 (March 1, 2021): 184-191. https://doi.org/10.18621/eurj.678454.
JAMA
1.Barut İ, Yüksel M, Kaya H, Engindeniz Z. Is the neutrophil/lymphocyte rate as effective as CURB-65 in the patient management of the community-acquired pneumonia patients admitted to the Emergency Medicine? Eur Res J. 2021;7:184–191.
MLA
Barut, İlker, et al. “Is the Neutrophil Lymphocyte Rate As Effective As CURB-65 in the Patient Management of the Community-Acquired Pneumonia Patients Admitted to the Emergency Medicine?”. The European Research Journal, vol. 7, no. 2, Mar. 2021, pp. 184-91, doi:10.18621/eurj.678454.
Vancouver
1.İlker Barut, Melih Yüksel, Halil Kaya, Zülfi Engindeniz. Is the neutrophil/lymphocyte rate as effective as CURB-65 in the patient management of the community-acquired pneumonia patients admitted to the Emergency Medicine? Eur Res J. 2021 Mar. 1;7(2):184-91. doi:10.18621/eurj.678454